Cargando…
Glycycoumarin Sensitizes Liver Cancer Cells to ABT-737 by Targeting De Novo Lipogenesis and TOPK-Survivin Axis
Glycycoumarin (GCM) is a representative of bioactive coumarin compounds isolated from licorice, an edible and medicinal plant widely used for treating various diseases including liver diseases. The purpose of the present study is to examine the possibility of GCM as a sensitizer to improve the effic...
Autores principales: | Zhang, Enxiang, Yin, Shutao, Lu, Xiaotong, Ye, Linhu, Fan, Lihong, Hu, Hongbo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5872771/ https://www.ncbi.nlm.nih.gov/pubmed/29543705 http://dx.doi.org/10.3390/nu10030353 |
Ejemplares similares
-
Glycycoumarin inhibits hepatocyte lipoapoptosis through activation of autophagy and inhibition of ER stress/GSK-3-mediated mitochondrial pathway
por: Zhang, Enxiang, et al.
Publicado: (2016) -
Glycycoumarin exerts anti-liver cancer activity by directly targeting T-LAK cell-originated protein kinase
por: Song, Xinhua, et al.
Publicado: (2016) -
Pharmacological Activities and Pharmacokinetics of Glycycoumarin
por: Tang, Yumei, et al.
Publicado: (2022) -
ABT-737 synergizes with Bortezomib to kill melanoma cells
por: Reuland, Steven N., et al.
Publicado: (2011) -
Comparison of in vitro antileukemic activity of obatoclax and ABT-737
por: Opydo-Chanek, Małgorzata, et al.
Publicado: (2016)